Bright Minds Biosciences Inc. (DRUG) P/S ratio

There is no P/S ratio history on record here for Bright Minds Biosciences Inc. (DRUG). Its statements are in CAD and its shares trade in USD, so figures at past share prices are not worked out. Figures as of 18 Nov 2026, 05:10 UTC, from Yahoo Finance.

Figures as of . Statements from Yahoo Finance. Figures, not advice.

Not enough data

A history of P/S ratio needs at least 3 fiscal years; none is on record here for Bright Minds Biosciences Inc.. Nothing is estimated to fill the gap.

Method

How it is calculated

The P/S ratio is the share price divided by revenue per share — the same thing as market value divided by revenue — taken at each fiscal year-end.

How to read it

It prices each unit of sales and still works when there is no profit; what counts as high depends on the margin those sales earn.

More on DRUG

Bright Minds Biosciences Inc., figure by figure

Bright Minds Biosciences Inc. (DRUG) overview: price, valuation and scorecard

Bright Minds Biosciences Inc. P/S ratio: questions and answers

How is Bright Minds Biosciences Inc.'s P/S ratio calculated?

The P/S ratio is the share price divided by revenue per share — the same thing as market value divided by revenue — taken at each fiscal year-end.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Bright Minds Biosciences Inc. (DRUG) P/S ratio”, data as of 18 November 2026. https://funkfolio.com/stock/DRUG/ps-ratio

Underlying data: Yahoo Finance.